International Clinics
Breaking
FDA approves venglustat, the first treatment for neurological symptoms of type 3 Gaucher disease
On 18 November 2026 the FDA approved Sanofi's Infilbray (venglustat).
On 18 November 2026 the FDA approved Sanofi's Infilbray (venglustat).
Confirmed Ebola cases in the Democratic Republic of the Congo reached 9,704 by 20 October 2026, including 4,687 deaths.
On 20 October 2026 the FDA approved GSK's Hibsago (bepirovirsen) injection for chronic hepatitis B.
Nothing more to show